1
A Study of SerpinPC in Participants With Hemophilia B (HemB) With Inhibitors
Condition(s):Hemophilia B With Inhibitor; Hemophilia BLast Updated:March 29, 2023Not yet recruiting
Hemophilia B With Inhibitor: 154 Clinical Trials, Page 1 of 16
Hide Studies Not Open or Pending
2
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
Condition(s):Haemophilia A With Inhibitors; Haemophilia B With InhibitorsLast Updated:August 25, 2023Active, not recruiting
3
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition(s):Hemophilia A With Inhibitor; Hemophilia B With InhibitorLast Updated:August 23, 2023Recruiting
4
Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors
Condition(s):Hemophilia A With Inhibitors; Hemophilia B With InhibitorsLast Updated:August 28, 2019Terminated
5
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B
Condition(s):Hemophilia A With Inhibitor; Hemophilia B With InhibitorLast Updated:December 17, 2021Terminated
6
Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors
Condition(s):Hemophilia A With Inhibitors; Hemophilia B With InhibitorsLast Updated:June 14, 2017Completed
7
Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors
Condition(s):Hemophilia A With Inhibitor; Hemophilia B With InhibitorLast Updated:September 10, 2022Completed
8
A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa
Condition(s):Hemophilia A With Inhibitors; Hemophilia B With InhibitorsLast Updated:February 25, 2022Completed
9
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
Condition(s):Hemophilia A With Inhibitor; Hemophilia B With InhibitorLast Updated:September 23, 2021Completed
10
Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.
Condition(s):Hemophilia A With Inhibitor; Hemophilia B With InhibitorLast Updated:February 24, 2021Unknown status